Bollard Group LLC Centessa Pharmaceuticals PLC Put Options Transaction History
Bollard Group LLC
- $4.37 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CNTA
# of Institutions
126Shares Held
122MCall Options Held
638KPut Options Held
146K-
Medicxi Ventures Management (Jersey) LTD20MShares$486 Million73.31% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$242 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$236 Million4.43% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.4MShares$204 Million0.2% of portfolio
-
Janus Henderson Group PLC London, X06.53MShares$159 Million0.04% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $2.3B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...